Trial ID or NCT#

NCT01926990

Status

recruiting iconRECRUITING

Purpose

This pilot clinical trial studies perfusion computed tomography (CT) in predicting response to treatment in patients with advanced kidney cancer. Comparing results of diagnostic procedures done before, during, and after targeted therapy may help doctors predict a patient's response to treatment and help plan the best treatment.

Official Title

Developing Non-Invasive Early Therapeutic Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Aya Kamaya, MD
Aya Kamaya, MD
Radiologist
Professor of Radiology (Body Imaging) at the Stanford University Medical Center
Alice C. Fan
Alice C. Fan
Medical oncologist, Genitourinary specialist
Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology at the Stanford University Medical Center
James D. Brooks
James D. Brooks
Surgical oncologist, Urologic surgeon
Keith and Jan Hurlbut Professor in the Stanford University School of Medicine
Sandy Srinivas
Sandy Srinivas
Medical oncologist, Urologic specialist, Genitourinary specialist
Professor of Medicine (Oncology) and, by courtesy, of Urology at the Stanford University Medical Center
Chiara Sabatti
Dominik Fleischmann
Dominik Fleischmann
Radiologist
Professor of Radiology (Cardiovascular Imaging) at the Stanford University Medical Center
Benjamin I. Chung
Benjamin I. Chung
Urologic oncologist, Urologic specialist, Urologist, Genitourinary specialist
Associate Professor of Urology at the Stanford University Medical Center
Dean W. Felsher
John Leppert

Contact us to find out if this trial is right for you.

CONTACT

Yoriko Imae
(650) 498-5186